BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PR, PGR, progesterone receptor
2512 results:

  • 1. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
    Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of pulmonary rehabilitation on patients with different chronic respiratory diseases during hospitalization.
    Shi XY; Ren Y; Gu XM; Jia YR; Wang X
    Medicine (Baltimore); 2024 Apr; 103(15):e37778. PubMed ID: 38608115
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The safety and efficacy of Compound Kushen Injection with chemoradiotherapy for the outcomes of lung and gastrointestinal cancers: A PRIMSA-compliant meta-analysis.
    Chen Y; Ma M; Xu F
    Medicine (Baltimore); 2024 Apr; 103(14):e36758. PubMed ID: 38579051
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preclinical Targeting of the pgrMC1-CK2 Axis with Silmitasertib: A Potential Strategy for lung Adenocarcinoma Therapy.
    Solaipriya S; Anbalagan M; Sivaramakrishnan V
    Drug Res (Stuttg); 2024 Apr; 74(4):187-190. PubMed ID: 38508228
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
    Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
    Corcoran RB; Do KT; Kim JE; Cleary JM; Parikh AR; Yeku OO; Xiong N; Weekes CD; Veneris J; Ahronian LG; Mauri G; Tian J; Norden BL; Michel AG; Van Seventer EE; Siravegna G; Camphausen K; Chi G; Fetter IJ; Brugge JS; Chen H; Takebe N; Penson RT; Juric D; Flaherty KT; Sullivan RJ; Clark JW; Heist RS; Matulonis UA; Liu JF; Shapiro GI
    Clin Cancer Res; 2024 May; 30(9):1739-1749. PubMed ID: 38456660
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
    Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
    Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
    Lin Y; Cao Q; Hong A; Liang X
    Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
    Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective.
    Dai F; Chen C; Zhou G; Wang X; Mei L; Luo N; Zhou W; Li T; Deng B; Liu L; Wang Y
    Thorac Cancer; 2024 Apr; 15(10):830-846. PubMed ID: 38414317
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study.
    Cheng WC; Lin CC; Liao WC; Lin YC; Chen CH; Chen HJ; Tu CY; Hsia TC
    BMC Cancer; 2024 Feb; 24(1):228. PubMed ID: 38373960
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pulmonary rehabilitation improves exercise capacity, health-related quality of life, and cardiopulmonary function in patients with non-small cell lung cancer.
    Huang CY; Hsieh MS; Hsieh PC; Wu YK; Yang MC; Huang SY; Tzeng IS; Lan CC
    BMC Cancer; 2024 Feb; 24(1):211. PubMed ID: 38360680
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
    Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
    Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination of Polygonatum Rhizoma and Scutellaria baicalensis triggers apoptosis through downregulation of PON
    Liu H; Yue L; Li Y; Zheng T; Zhang W; Li C; Zhuang W; Fan L
    Environ Toxicol; 2024 May; 39(5):3172-3187. PubMed ID: 38348599
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
    Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
    World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.
    Wang Y; Hu C; Yu H; Hu J; Zhou Z; Fu N; Huang X; Kong F; Wang W; Liu J
    Lung Cancer; 2024 Mar; 189():107495. PubMed ID: 38335691
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
    Kikuchi K; Ogawa M; Sasaki A
    J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 126.